uniQure N.V. - Ordinary Shares — Cash Flow (NASDAQ:QURE) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -134.83 M287.96 M-145.06 M-145.93 M-182.73 M-177.96 M -172.11 M Cash from investing activities -9.48 M-67.39 M-182.73 M-205.69 M162.97 M-321.62 M -243.16 M Cash from financing activities 7.44 M94.86 M1.45 M362.72 M-59.49 M415.4 M 335.28 M Free cash flow -134.83 M287.96 M-145.06 M-145.93 M-182.73 M-178.4 M -172.56 M

uniQure N.V. - Ordinary Shares

uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.

News

Biotech Investors Are Tuning Out the MAHA Chaos

uniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates

Kyverna Therapeutics: 'Strong Buy' On Additional POC Of Miv-Cel In Myasthenia Gravis

Nurix Therapeutics (NRIX) Moves 6.9% Higher: Will This Strength Last?

uniQure Investors Sue Company Over Huntington’s Disease Drug Study Claims - TipRanks.com

Biotechs Breathe Easy As Vinay Prasad Plans His Exit. But Should They?

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors

A Unique Situation For UniQure (QURE)

Mizuho upgrades uniQure stock rating on FDA leadership change

Avago, Lumentum among market cap stock movers on Monday

Chardan raises uniQure stock price target on FDA leadership change

Tesla and Facebook among market cap stock movers on Monday